Nuclear Medicine: Page 71

PET/CT predicts success of rad therapy for spinal mets

By Wayne Forrest

FDG-PET/CT scans can predict the success of radiation therapy in patients with spinal metastases, especially in regard to progression-free survival, according to a study published online September 28 in PLOS One.

October 2, 2018

PET/MRI motion correction gives readers more confidence

By Wayne Forrest

A motion correction algorithm applied to PET/MRI scans resulted in more accurate scans with fewer false positives, and readers were more confident in their interpretations, according to study results published in the September issue of the Journal of Nuclear Medicine.

October 1, 2018

FluoroPharma restructures CardioPET license with MGH

By AuntMinnie.com staff writers

Radiopharmaceutical developer FluoroPharma Medical has restructured its license agreement with Massachusetts General Hospital (MGH) in Boston for the radiopharmaceutical CardioPET.

September 26, 2018

PET/CT key to NIH's tuberculosis research plan

By AuntMinnie.com staff writers

The U.S. National Institute of Allergy and Infectious Diseases has published a new plan for tuberculosis research, and imaging -- particularly PET/CT -- is a key part of the strategy. The document was released on September 26 to coincide with the United Nations General Assembly meeting in New York City on ending tuberculosis.

September 25, 2018

FDG-PET/CT helps stage men with breast cancer, too

By Wayne Forrest

Assessing breast cancer in men is an uncommon clinical use for FDG-PET/CT, but the hybrid modality achieves results comparable to those in women in regard to accurate staging of the disease, according to a study published online September 21 in the Journal of Nuclear Medicine.

September 25, 2018

Ga-68 PSMA-11 PET/MRI advances prostate cancer detection

By Wayne Forrest

PET/MRI scans with a gallium-68 (Ga-68)-labeled radiopharmaceutical that homes in on prostate-specific membrane antigen (PSMA)-11 could become a mainstay in prostate cancer detection, given its ability to significantly outperform multiparametric MRI alone, according to a study published online September 18 in Radiology.

September 24, 2018

Flortaucipir-PET targets tau for Alzheimer's diagnoses

By Wayne Forrest

By binding to the tau protein associated with Alzheimer's, PET imaging with the tracer flortaucipir can distinguish between the disease and other neurodegenerative conditions with similar symptoms, according to an international study published in the September 18 issue of the Journal of the American Medical Association.

September 20, 2018

Japanese researchers receive SNMMI fellowship

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has announced the recipients of its 2018-2020 SNMMI Wagner-Torizuka Fellowship.

September 19, 2018

Navidea enters NIH CAP program, raises $3M

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals said it has been accepted by the U.S. National Institutes of Health (NIH) Commercialization Accelerator Program (CAP) for 2018-2019. The firm also announced it has raised $3 million in a private placement.

September 17, 2018

Delayed NaF-PET enhances coronary plaque detection

By Wayne Forrest

In life, timing is everything. With sodium fluoride (NaF) PET, interpreting results three hours after tracer injection instead of the customary one-hour delay improved image quality and standardized uptake values, leading to significantly better coronary plaque detection, according to a September  13 article in the Journal of Nuclear Medicine.

September 17, 2018

NorthStar promotes Merrick to CEO

By AuntMinnie.com staff writers

NorthStar Medical Technologies has promoted Stephen Merrick, formerly president and chief operating officer, to president and CEO.

September 16, 2018

PET/CT makes case for directing cervical cancer treatment

By Wayne Forrest

Can FDG-PET/CT be used to direct the treatment of locally advanced cervical cancer by determining which patients should receive more extensive chemoradiation therapy or palliative care? Maybe, but findings from a new study published online September 14 in JAMA Network Open are equivocal.

September 14, 2018

Previous Page

Page 71 of 440

Next Page